From the Journals

COVID-19 antibody response not reduced with diabetes

Publish date: October 20, 2020

 

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

For COVID-19 plus diabetes, glycemic control tops treatment list
MDedge ObGyn
Daily Recap: FDA revokes emergency use of hydroxychloroquine; Hardest hit specialties ranked in financial report
MDedge ObGyn
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
MDedge ObGyn
Daily Recap: Lifestyle vs. genes in breast cancer showdown; Big pharma sues over insulin affordability law
MDedge ObGyn
Good for profits, good for patients: A new form of medical visits
MDedge ObGyn
Novel program cuts weight retention after gestational diabetes
MDedge ObGyn
COVID-19 taking financial toll on people in U.S. with diabetes
MDedge ObGyn
Does metformin reduce risk for death in COVID-19?
MDedge ObGyn
SGLT2 inhibitors with metformin look safe for bone
MDedge ObGyn
Smart health devices – promises and pitfalls
MDedge ObGyn